^US 2010004226, Cook JM, Hao H, Huang S, Sarma PV, Zhang C, "Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects", published 7 January 2010
^“Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach”. Journal of Medicinal Chemistry43 (1): 71–95. (January 2000). doi:10.1021/jm990341r. PMID106330396
^US 7119196, Cook JM, Huang Q, He X, Li X, Yu J, Han D, Lelas S, McElroy JF, "Anxiolytic agents with reduced sedative and ataxic effects", issued 10 September 2006, assigned to WiSys Technology Foundation Inc
^“Benzo-fused benzodiazepines employed as topological probes for the study of benzodiazepine receptor subtypes”. Medicinal Chemistry Research6 (3): 384–391. (1996).
^“Contribution of alpha 1GABAA and alpha 5GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys”. The Journal of Pharmacology and Experimental Therapeutics313 (2): 658–67. (May 2005). doi:10.1124/jpet.104.080275. PMID15650112.